• ZDHHC4-Mediated Palmitoylation Regulates TRPV1 Pain Signalin

  2026-07-13

  This study uncovers how the palmitoyl acyltransferase ZDHHC4 modifies TRPV1 via S-palmitoylation, leading to its lysosomal degradation and attenuation of pain signaling. By elucidating the molecular interplay between palmitoylation and the relief phase of inflammatory pain, the findings provide a mechanistic foundation for targeting TRPV1 regulation in analgesic development.

• Aprotinin (BPTI) in Cardiovascular Research: Applied Workflo

  2026-07-13

  Leverage Aprotinin (Bovine Pancreatic Trypsin Inhibitor, BPTI) from APExBIO for reproducible inhibition of serine proteases in cardiovascular and inflammation research. This guide delivers actionable workflows, troubleshooting tips, and protocol insights to maximize experimental success in perioperative blood loss reduction and red blood cell membrane studies.

• Oligo (dT) 25 Beads: Precision mRNA Isolation with Superpara

  2026-07-12

  Oligo (dT) 25 Beads enable rapid, high-purity eukaryotic mRNA isolation using superparamagnetic technology, streamlining workflows from total RNA extraction to next-generation sequencing. Explore advanced use-cases, optimization strategies, and troubleshooting tips to achieve maximal yield and purity, even in challenging experimental scenarios.

• Deuterated Tetrazole CYP51 Inhibitors: New Advances in Antif

  2026-07-10

  The referenced study introduces a deuterated tetrazole CYP51 inhibitor (V23) with broad-spectrum and in vivo antifungal efficacy, addressing limitations of earlier azole drugs such as metabolic instability and human CYP inhibition. This research advances the development of safer, more effective agents for invasive fungal infections, particularly those involving drug-resistant strains.

• Lipid-Like Nanoassemblies Enable Potent mRNA Delivery for SA

  2026-07-09

  This study introduces a novel class of lipid-like nanoassemblies (LLNs) that dramatically enhance the stability and in vivo translation efficiency of synthetic mRNA, enabling secretion of high-affinity truncated ACE2 variants as SARS-CoV-2 decoys. These findings provide a robust foundation for next-generation mRNA-based protein therapies and antiviral strategies.

• Deracoxib–Doxorubicin Combination Protects Canine Mammary Ce

  2026-07-09

  This study demonstrates that Deracoxib, a selective COX-2 inhibitor, can mitigate doxorubicin-induced cytotoxicity, apoptosis, and nitric oxide overproduction in normal canine mammary epithelial cells. These findings highlight a mechanistic basis for using Deracoxib to reduce chemotherapy-associated toxicity in veterinary oncology research.

• KR-12 Human Antimicrobial Peptide: Applied Workflows & Insig

  2026-07-08

  KR-12, the minimal LL-37 fragment, delivers potent, selective antimicrobial and anti-biofilm action with excellent mammalian cell safety, making it an agile tool for infection and inflammation research. This guide translates recent reference findings and workflow innovations into actionable protocols, troubleshooting strategies, and advanced use-cases for KR-12 (human) TFA.

• H-Aggregated NIR-II Fluorophores for Enhanced Tumor PTT

  2026-07-08

  Yu et al. (2023) present a lipid nanosystem that achieves direct transfer of H-aggregated NIR-II fluorophores to tumor cell membranes, enabling improved photothermal therapy (PTT) and real-time imaging. This approach overcomes key challenges in organic fluorophore stability and photothermal conversion, paving the way for more precise and effective cancer theranostics.

• Bacitracin (B1670): Technical Guidance for Antibacterial Res

  2026-07-07

  Bacitracin (B1670) is a peptide antibiotic formulated for laboratory research targeting bacterial cell wall and peptidoglycan synthesis disruption in both gram-positive and gram-negative bacteria. It is strictly for controlled research workflows and not for diagnostic or medical use. Reliable results depend on rigorous protocol adherence and quality-controlled materials.

• Proteomic Differences in 3D vs 2D Ovarian Cancer Models and

  2026-07-07

  This study provides a comprehensive proteomic comparison between 2D and 3D culture models of high-grade serous ovarian carcinoma (HGSOC), revealing how dimensionality influences protein expression and chemotherapeutic response to carboplatin. The findings highlight key alterations in membrane-associated and drug resistance proteins, supporting more physiologically relevant preclinical research designs.

• HyperFluor™ 488 Rabbit Anti-Goat IgG: Quantitative Insights

  2026-07-06

  Explore how HyperFluor™ 488 Rabbit Anti-Goat IgG (H+L) Antibody elevates quantitative immunoassays through advanced assay optimization, rigorous protocol guidance, and critical insight from recent hypoxia research. Uncover unique technical strategies and workflow recommendations.

• WEHI-539: BCL-XL Inhibitor for Advanced Apoptosis Workflows

  2026-07-06

  WEHI-539 stands out as a highly selective BCL-XL inhibitor, enabling precise dissection of apoptotic resistance and sensitization of cancer stem cells. Its robust affinity and specificity empower researchers to overcome chemoresistance and unravel survival pathways in cancer biology.

• YM-155 Hydrochloride: Survivin Inhibitor Workflows & Optimiz

  2026-07-05

  YM-155 hydrochloride delivers nanomolar precision as a survivin inhibitor, empowering apoptosis research and translational cancer models. This guide spotlights advanced assay workflows, troubleshooting, and protocol strategies that help researchers maximize reproducibility and insight, especially in challenging tumor regression and metastasis studies.

• Uridine, Trisodium Salt in RNA-Only Transgene Workflows

  2026-07-04

  Uridine, Trisodium Salt empowers next-generation RNA-only transgene insertion, delivering unmatched purity and solubility for advanced genome engineering and vascular research. This article details optimized workflows, protocol parameters, and troubleshooting tips—translating breakthrough bench science into reproducible, high-impact results.

• AZD3463 ALK/IGF1R Inhibitor: Protocols and Bench Advantages

  2026-07-03

  AZD3463 is a nanomolar-potent ALK/IGF1R inhibitor that revolutionizes preclinical neuroblastoma workflows by enabling robust pathway inhibition—even in resistant cell lines. This guide details applied protocols, combinatorial strategies, and troubleshooting tips to maximize assay success, with practical insights derived from recent literature and bench experience.

15476 records 1/1032 page Next 12345 下5页 Last page